These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2178223)
1. Site-directed mutations of human growth hormone that selectively modify its lactogenic activity and binding properties. Binder L; Gertler A; Elberg G; Guy R; Vogel T Mol Endocrinol; 1990 Jul; 4(7):1060-8. PubMed ID: 2178223 [TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity. Helman D; Staten NR; Byatt J; Grosclaude J; McKinnie RE; Djiane J; Gertler A Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914 [TBL] [Abstract][Full Text] [Related]
3. N-terminal-truncated recombinant analogs of bovine placental lactogen: interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes. Vashdi-Elberg D; Staten NR; Sakal E; Krivi GG; Gertler A Endocrinology; 1995 Mar; 136(3):1258-66. PubMed ID: 7867580 [TBL] [Abstract][Full Text] [Related]
4. Chimeric bovine-human growth hormone prepared by recombinant DNA technology: binding properties and biological activity. Binder L; Vogel T; Hadary D; Elberg G; Gertler A Mol Endocrinol; 1989 Jun; 3(6):923-30. PubMed ID: 2739655 [TBL] [Abstract][Full Text] [Related]
5. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Hansen BS; Hjorth S; Welinder BS; Skriver L; De Meyts P Endocrinology; 1993 Dec; 133(6):2809-17. PubMed ID: 8243308 [TBL] [Abstract][Full Text] [Related]
6. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities. Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288 [TBL] [Abstract][Full Text] [Related]
7. Analysis of growth hormone and lactogenic binding sites cross-linked to iodinated human growth hormone. Hughes JP; Simpson JS; Friesen HG Endocrinology; 1983 Jun; 112(6):1980-5. PubMed ID: 6303751 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH. Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826 [TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of hGH at the 54-74 loop selectively modifies its lactogenic receptor-mediated biological activity. Sakal E; Tchelet A; Uchida E; Shimokawa S; Nishikawa S; Hayakawa T; Krivi GG; Gertler A Mol Cell Endocrinol; 1993 Nov; 97(1-2):129-34. PubMed ID: 8143895 [TBL] [Abstract][Full Text] [Related]
10. Indication of different lactogen and somatogen binding sites in the human growth hormone molecule as probed with monoclonal antibodies. Strasburger CJ; Binder L; Elberg G; Cohen-Chapnik N; Kohen F; Gertler A Mol Cell Endocrinol; 1989 Nov; 67(1):55-62. PubMed ID: 2482210 [TBL] [Abstract][Full Text] [Related]
11. Preparation, purification, and determination of the biological activities of 12 N terminus-truncated recombinant analogues of bovine placental lactogen. Gertler A; Hauser SD; Sakal E; Vashdi D; Staten N; Freeman JJ; Krivi GG J Biol Chem; 1992 Jun; 267(18):12655-9. PubMed ID: 1618771 [TBL] [Abstract][Full Text] [Related]
12. Solubilization and characterization of a lactogenic receptor from human placental chorion membranes. Ormandy CJ; Clarke CL; Sutherland RL J Cell Biochem; 1990 May; 43(1):1-15. PubMed ID: 2161413 [TBL] [Abstract][Full Text] [Related]
13. Novel recombinant analogues of bovine placental lactogen. G133K and G133R provide a tool to understand the difference between the action of prolactin and growth hormone receptors. Helman D; Staten NR; Grosclaude J; Daniel N; Nespoulous C; Djiane J; Gertler A J Biol Chem; 1998 Jun; 273(26):16067-74. PubMed ID: 9632658 [TBL] [Abstract][Full Text] [Related]
15. Human growth hormone-variant is a biologically active somatogen and lactogen. MacLeod JN; Worsley I; Ray J; Friesen HG; Liebhaber SA; Cooke NE Endocrinology; 1991 Mar; 128(3):1298-302. PubMed ID: 1999151 [TBL] [Abstract][Full Text] [Related]
16. Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities. Bustamante JJ; Grigorian AL; Muñoz J; Aguilar RM; Treviño LR; Martinez AO; Haro LS Growth Horm IGF Res; 2010 Aug; 20(4):298-304. PubMed ID: 20472479 [TBL] [Abstract][Full Text] [Related]
17. Extracellular domain of prolactin receptor from bovine mammary gland: expression in Escherichia coli, purification and characterization of its interaction with lactogenic hormones. Tchelet A; Staten NR; Creely DP; Krivi GG; Gertler A J Endocrinol; 1995 Mar; 144(3):393-403. PubMed ID: 7738463 [TBL] [Abstract][Full Text] [Related]
18. Alteration in the receptor binding specificity of human growth hormone by genomic exon exchange. Ray J; Okamura H; Kelly PA; Liebhaber SA; Cooke NE Mol Endocrinol; 1990 Jan; 4(1):101-7. PubMed ID: 2157972 [TBL] [Abstract][Full Text] [Related]